| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,530,000,000 |
| Market
Cap: |
331.94(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$100.18 - $131.95 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
| |
MAJOR MARKET |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 330 |
| Guru Rank Value : 3.8 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
409 |
| Total Buy Value |
$0 |
$0 |
$0 |
$44,337 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
8 |
| Total Shares Sold |
409,617 |
455,521 |
560,285 |
4,068,540 |
| Total Sell Value |
$51,615,837 |
$56,431,566 |
$68,728,071 |
$427,246,334 |
| Total People Sold |
8 |
9 |
10 |
12 |
| Total Sell Transactions |
9 |
11 |
19 |
48 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nally Michael |
EVP, Chief Marketing Officer |
• – – |
2019-05-04 |
4 |
D |
$80.00 |
$29,600 |
D/D |
(370) |
2,565 |
|
- |
|
| Nally Michael |
EVP, Chief Marketing Officer |
• – – |
2019-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,298 |
2,935 |
|
- |
|
| Deluca Richard R. |
EVP&Pres, Merck Animal Heallth |
• – – |
2019-05-03 |
4 |
S |
$80.00 |
$2,800,000 |
D/D |
(35,000) |
71,064 |
|
- |
|
| Deluca Richard R. |
EVP&Pres, Merck Animal Heallth |
• – – |
2019-05-03 |
4 |
OE |
$39.29 |
$1,375,150 |
D/D |
35,000 |
106,064 |
|
- |
|
| Davis Robert M |
EVP, Global Svcs & CFO |
• • – |
2019-03-25 |
4 |
AS |
$82.38 |
$15,863,119 |
D/D |
(192,572) |
137,660 |
|
- |
|
| Davis Robert M |
EVP, Global Svcs & CFO |
• • – |
2019-03-25 |
4 |
OE |
$58.22 |
$11,211,542 |
D/D |
192,572 |
330,232 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-20 |
4 |
AS |
$82.05 |
$15,813,372 |
D/D |
(192,736) |
797,715 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-20 |
4 |
OE |
$39.29 |
$7,572,597 |
D/D |
192,736 |
990,451 |
|
- |
|
| Fleming Michael |
SVP Chief Ethics & Com Officer |
• – – |
2019-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,345 |
|
- |
|
| Coe Mary Ellen |
Director |
– • – |
2019-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-13 |
4 |
AS |
$82.00 |
$1,535,454 |
D/D |
(18,725) |
797,715 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-13 |
4 |
OE |
$39.29 |
$735,705 |
D/D |
18,725 |
816,440 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-05 |
4 |
AS |
$82.00 |
$570,809 |
D/D |
(6,961) |
797,715 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-05 |
4 |
OE |
$39.29 |
$273,498 |
D/D |
6,961 |
804,676 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-04 |
4 |
AS |
$82.01 |
$1,077,875 |
D/D |
(13,144) |
797,715 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-03-04 |
4 |
OE |
$39.29 |
$516,428 |
D/D |
13,144 |
810,859 |
|
- |
|
| Perlmutter Roger M |
Exe V-P & Pres, MRL |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$2,647,476 |
D/D |
32,937 |
175,336 |
|
- |
|
| Clyburn Frank |
EVP, Chief Commercial Officer |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$322,886 |
D/D |
4,017 |
66,189 |
|
- |
|
| Frazier Kenneth C |
Chairman, President & CEO |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$8,501,391 |
D/D |
105,765 |
797,715 |
|
- |
|
| Gerberding Julie L. |
EVP Strat Comm, Gl Pub Policy |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$703,084 |
D/D |
8,747 |
55,288 |
|
- |
|
| Chattopadhyay Sanat |
Exe V-P & Pres. MMD |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$834,344 |
D/D |
10,380 |
61,847 |
|
- |
|
| Deluca Richard R. |
EVP&Pres, Merck Animal Health |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$1,085,693 |
D/D |
13,507 |
70,585 |
|
- |
|
| Karachun Rita A |
Sr. VP Fince-Global Controller |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$187,285 |
D/D |
2,330 |
18,505 |
|
- |
|
| Nally Michael |
EVP, Chief Marketing Officer |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$122,740 |
D/D |
1,527 |
1,527 |
|
- |
|
| Davis Robert M |
EVP, Global Svcs & CFO |
• • – |
2019-02-25 |
4 |
A |
$80.38 |
$2,460,432 |
D/D |
30,610 |
137,660 |
|
- |
|
1215 Records found
|
|
Page 16 of 49 |
|
|
0.48 (0.37%) 
